Cargando…

Soluble Alpha Klotho in Acromegaly: Comparison With Traditional Markers of Disease Activity

CONTEXT: Soluble alpha klotho (sαKL) has been linked to growth hormone (GH) action, but systematic evaluation and comparisons with traditional biomarkers in acromegaly are lacking. OBJECTIVE: To evaluate the potential of sαKL to aid classification of disease activity. METHODS: This retrospective stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schweizer, Júnia R O L, Schilbach, Katharina, Haenelt, Michael, Giannetti, Alexandre V, Bizzi, Mariana F, Soares, Beatriz S, Paulino, Eduardo, Schopohl, Jochen, Störmann, Sylvère, Ribeiro-Oliveira, Antônio, Bidlingmaier, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277223/ https://www.ncbi.nlm.nih.gov/pubmed/33864468 http://dx.doi.org/10.1210/clinem/dgab257

Ejemplares similares

OR32-2 Alpha Klotho as a Marker of Disease Activity in Acromegaly
por: Schweizer, Junia, et al.
Publicado: (2019)

MON-327 Soluble Alpha Klotho and IGF-I Before Surgery as Prognostic Factors to Acromegaly Long-term Remission
por: de Oliveira Longo Schweizer, Junia Ribeiro, et al.
Publicado: (2020)

THU056 Reference Interval For Serum Soluble Alpha Klotho, A Sensitive Biomarker Of Growth Hormone (GH) Excess
por: de Oliveira Longo Schweizer, Júnia Ribeiro, et al.
Publicado: (2023)

SUN-LB61 Differential and Opposite Regulation of Acid Labile Subunit (ALS) Versus Insulin-Like Growth Factor I (IGF-I) by Oral Estrogens in Premenopausal Women
por: Schilbach, Katharina, et al.
Publicado: (2020)

Delving into Acromegaly
por: Störmann, Sylvère, et al.
Publicado: (2023)

Can Growth Hormone Lead to a Faster Recovery from Guillain-Barré Syndrome? Case Report of the First Therapeutic Use in One Patient
por: Amereller, Felix, et al.
Publicado: (2023)

Let’s focus more on regional diversity of acromegaly
por: Störmann, Sylvère
Publicado: (2022)

SUN-LB62 Differential Regulation of 22 kDa and 20 kDa Growth Hormone Isoforms in Response to Acute Glucose Load and Moderate Intensity Exercise
por: Haenelt, Michael, et al.
Publicado: (2020)

Differences between immunotherapy-induced and primary hypophysitis—a multicenter retrospective study
por: Amereller, Felix, et al.
Publicado: (2021)

Soluble Klotho protein as a novel serum biomarker in patients with acromegaly
por: Dąbrowska, Anna M., et al.
Publicado: (2014)

Soluble Klotho: a possible predictor of quality of life in acromegaly patients
por: Coopmans, Eva C., et al.
Publicado: (2020)

In active acromegaly, IGF1 bioactivity is related to soluble Klotho levels and quality of life
por: Varewijck, A J, et al.
Publicado: (2014)

Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly
por: Strasburger, Christian J, et al.
Publicado: (2016)

Clinical Presentation and Management of Patients With Acromegaly at a University Hospital
por: Leao, Felipe A, et al.
Publicado: (2021)

Aging and sex affect soluble alpha klotho levels in bonobos and chimpanzees
por: Behringer, V., et al.
Publicado: (2018)

Soluble Alpha-Klotho Alleviates Cardiac Fibrosis without Altering Cardiomyocytes Renewal
por: Chen, Wei-Yu
Publicado: (2020)

Growth hormone: isoforms, clinical aspects and assays interference
por: Ribeiro de Oliveira Longo Schweizer, Júnia, et al.
Publicado: (2018)

Health Outcomes in Acromegaly: Depression and Anxiety are Promising Targets for Improving Reduced Quality of Life
por: Geraedts, Victor Jacobus, et al.
Publicado: (2015)

New Insights into the Mechanism of Action of Soluble Klotho
por: Dalton, George D., et al.
Publicado: (2017)

What do international health electives and state examination scores have in common? – A cohort study to compare the results of written medical licensing examinations with the participation in international health electives during the final year of undergraduate medical education in Germany
por: Störmann, Sylvère, et al.
Publicado: (2018)

Association of pre- and postoperative αKlotho levels with long-term remission after pituitary surgery for acromegaly
por: Neidert, Marian Christoph, et al.
Publicado: (2022)

Soluble klotho may be a marker of phosphate reabsorption
por: Tan, Sven-Jean, et al.
Publicado: (2017)

Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis
por: Memmos, Evangelos, et al.
Publicado: (2019)

Soluble klotho as an effective biomarker to characterize inflammatory states
por: Wu, Shou-En, et al.
Publicado: (2022)

Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment
por: Martín-Vírgala, Julia, et al.
Publicado: (2023)

The Use of IGF-I to Monitor Long-Acting Growth Hormone Therapy—Timing is an Art…
por: Bidlingmaier, Martin, et al.
Publicado: (2021)

Laboratory investigations in the diagnosis and follow-up of GH-related disorders
por: Schilbach, Katharina, et al.
Publicado: (2019)

Soluble α-Klotho Serum Levels in Chronic Kidney Disease
por: Rotondi, Silverio, et al.
Publicado: (2015)

Performance of soluble Klotho assays in clinical samples of kidney disease
por: Neyra, Javier A, et al.
Publicado: (2019)

Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly
por: Clemmons, David R., et al.
Publicado: (2023)

Association of Soluble Klotho Level with Adverse Outcomes in Patients on Maintenance Hemodialysis
por: Yu, Li-xia, et al.
Publicado: (2020)

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel(®) therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension
por: Melmed, Shlomo, et al.
Publicado: (2009)

Brazilian multicenter study on pegvisomant treatment in acromegaly
por: Boguszewski, Cesar L., et al.
Publicado: (2019)

A Case of Self-salvation in a Determined Chloroquine Suicide Attempt
por: Störmann, Sylvère, et al.
Publicado: (2021)

Association between Serum Soluble Klotho Levels and Mortality in Chronic Hemodialysis Patients
por: Otani-Takei, Naoko, et al.
Publicado: (2015)

Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients
por: Buiten, Maurits S, et al.
Publicado: (2014)

Soluble klotho as a marker of renal fibrosis and podocyte injuries in human kidneys
por: Cho, Nam-Jun, et al.
Publicado: (2018)

Interactions of sclerostin with FGF23, soluble klotho and vitamin D in renal transplantation
por: Tartaglione, Lida, et al.
Publicado: (2017)

Soluble Klotho Improves Hepatic Glucose and Lipid Homeostasis in Type 2 Diabetes
por: Gu, Huiying, et al.
Publicado: (2020)

Soluble klotho regulates the function of salivary glands by activating KLF4 pathways
por: Tai, Nguyen Chi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5hlc1fmt301ungt3qsc2bt198q